drug
inhibit
viru
replic
becom
mainstay
treatment
acut
chronic
rna
dna
viru
infect
howev
interest
antivir
drug
infect
anim
much
slower
develop
especi
true
cat
suffer
sever
chronic
viral
infect
resembl
peopl
infecti
agent
includ
felin
leukemia
immunodefici
virus
felv
fiv
respect
felin
herpesviru
fhv
virul
system
coronaviru
caus
felin
infecti
periton
fipv
felv
fiv
infect
control
test
isol
andor
vaccin
fhvassoci
diseas
first
felin
viral
infect
incorpor
antivir
highli
fatal
system
caliciviru
affect
small
number
cat
fipv
infect
best
candid
antivir
drug
develop
vaccin
ineffect
multicat
environ
make
prevent
extrem
difficult
kill
cat
around
emerg
exot
diseas
ebola
middl
east
respiratori
syndrom
sever
acut
respiratori
syndrom
peopl
prompt
intens
research
drug
inhibit
rna
viru
replic
one
promis
antivir
drug
emerg
rna
virus
adenosin
nucleosid
monophosph
prodrug
remdesivir
gilead
scienc
effect
prevent
experiment
ebola
rhesu
inhibit
epidem
zoonot
coronavirus
tissu
cultur
mous
infect
promis
find
prompt
initi
research
parent
nucleosid
fipv
infect
found
compar
valu
fipv
cat
cell
therefor
decid
concentr
less
chemic
complex
test
laboratori
cat
pharmacokinet
studi
two
laboratori
cat
demonstr
sustain
effect
plasma
level
h
follow
singl
dose
given
subcutan
sc
intraven
iv
result
extend
laboratori
cat
experiment
induc
abdomin
effus
felin
infecti
periton
fip
studi
show
highli
effect
experiment
fip
open
way
present
field
trial
goal
studi
demonstr
safeti
efficaci
treatment
cat
natur
occur
fip
smallmolecul
drug
dalton
weight
around
nm
size
easili
enter
cell
interact
key
target
molecul
unlik
publish
substanc
drug
inhibit
fipv
hamper
cellular
process
usurp
virus
small
molecul
like
interfer
directli
replic
process
encod
provid
gilead
scienc
pure
highli
stabl
powder
dilut
concentr
mgml
ethanol
propylen
glycol
peg
water
ph
hci
mixtur
place
steril
ml
glass
inject
bottl
agit
suspens
place
sonic
water
bath
min
clear
dilut
drug
refriger
use
within
week
studi
conduct
protocol
approv
institut
anim
care
use
committe
clinic
trial
review
board
veterinari
medic
teach
hospit
vmth
clinic
trial
committe
univers
california
uc
davi
institut
rule
preclud
use
diseas
cat
obtain
directli
shelter
kitten
fosterrescu
group
thu
requir
cat
legal
ownedadopt
treat
specif
condit
owner
consent
supplementari
materi
studi
incorpor
control
group
effect
treatment
compar
placebo
treatment
group
includ
given
preparatori
vitro
vivo
studi
indic
would
safe
effect
cat
fip
recruit
owner
veterinarian
seek
current
treatment
option
access
earlier
antivir
drug
initi
diagnosi
fip
base
primarili
characterist
signal
clinic
histori
diseas
sign
routin
laboratori
test
result
examin
abdomin
thorac
effus
definit
diagnosi
base
rtpcr
immunohistochemistri
desir
essenti
inclus
cat
obviou
ocular
neurolog
diseas
discourag
enter
trial
concern
abil
antivir
drug
includ
penetr
thirtyon
cat
owner
ultim
recruit
tabl
owner
repres
cat
came
uc
davi
initi
treatment
five
owner
cat
treat
local
veterinarian
cat
seen
uc
davi
reevalu
fip
diagnosi
reconfirm
base
signal
clinic
histori
physic
examin
prior
laboratori
test
result
repeat
complet
blood
count
cbc
serum
protein
effus
analys
thorac
abdomin
effus
cat
wet
fip
confirm
posit
fipv
rna
cat
sign
noneffus
fip
test
abdomin
thorac
ultrasonographi
primari
lesion
ocular
diseas
confirm
ophthalmolog
servic
vmth
uc
davi
neurolog
statu
case
possibl
central
nervou
system
diseas
sign
evalu
vmth
neurolog
servic
initi
dosag
regimen
mgkg
sc
base
earlier
tissu
cultur
experi
pharmacokinet
studi
laboratori
minimum
treatment
period
week
base
experi
proteas
inhibitor
natur
occur
treatment
extend
one
week
cat
still
abnorm
serum
protein
valu
dosag
increas
later
stage
trial
mgkg
case
treatment
extend
diseas
relaps
occur
owner
sent
new
suppli
drug
everi
week
form
preload
ml
luer
lock
syring
inch
g
luer
hub
needl
syring
store
refriger
warm
room
temperatur
prior
inject
inject
space
across
dorsum
cm
behind
shoulder
blade
midlumbar
area
onehalf
distanc
adjac
chest
flank
cat
taken
nonessenti
treatment
antibiot
corticosteroid
interferon
pentoxifyllin
nonsteroid
antiinflammatori
drug
pain
relief
medic
time
entri
trial
monitor
everi
h
stay
uc
davi
temperatur
appetit
activ
urin
defec
blood
also
taken
day
interv
evalu
hematocrit
total
protein
bilirubin
white
blood
cell
count
white
cell
differenti
count
ascit
sampl
collect
entri
one
day
interv
long
possibl
test
level
fipv
rna
transcript
quantit
q
rtpcr
idexx
molecular
diagnost
immunohistochemistri
fipv
nucleocapsid
protein
perform
formalinfix
tissu
section
five
cat
necropsi
cat
discharg
owner
signific
favor
respons
treatment
note
usual
within
day
owner
instruct
time
properli
give
subcutan
inject
drug
encourag
continu
daili
log
bodi
temperatur
activ
appetit
defec
urin
weekli
bodi
weight
measur
cbc
serum
chemistri
panel
done
monthli
interv
local
veterinarian
visit
vmth
abnorm
sign
behavior
note
promptli
report
euthanasia
requir
usual
conduct
owner
veterinarian
possibl
uc
davi
bodi
seal
plastic
bag
immedi
refriger
ship
within
day
less
insul
contain
icepack
uc
davi
overnight
express
mail
necropsi
perform
one
author
ml
anatom
patholog
servic
school
veterinari
medicin
uc
davi
owner
request
final
disposit
bodi
honor
thirtyon
cat
rang
month
age
mean
month
enrol
trial
tabl
eighteen
cat
domest
short
longhair
pedigre
differ
breed
tabl
domest
cat
adopt
kittenfost
rescu
organ
n
formal
shelter
n
obtain
neighborhood
stray
n
studi
includ
femal
seven
intact
seven
spay
male
one
intact
castrat
twentysix
cat
present
effus
fip
six
thorac
abdomin
five
cat
present
noneffus
fip
four
diseas
local
abdomen
mesenter
ileocecalcol
lymph
node
one
chest
lung
hilar
lymph
node
tabl
four
cat
indic
earlier
noneffus
fip
progress
effus
form
tabl
gross
sign
ocular
diseas
consist
underli
fip
confirm
ophthalmoscop
examin
three
cat
two
cat
either
reluct
longer
abl
jump
higher
place
suggest
neurolog
involv
four
cat
euthan
die
within
first
day
sever
diseas
complic
fifth
cat
euthan
day
owe
lack
treatment
respons
figur
treatment
period
interrupt
except
three
cat
given
week
respit
week
cat
week
cat
problem
give
inject
skin
reaction
figur
cat
treat
second
relaps
rather
week
rise
blood
urea
serum
level
symmetr
dimethylarginin
sdma
clinic
respons
cat
complet
least
week
treatment
dramat
fever
usual
resolv
within
h
figur
concurr
mark
daili
improv
appetit
activ
level
weight
gain
abdomin
effus
rapidli
disappear
week
period
start
around
day
posttreat
cat
thorac
effus
usual
dyspneic
upon
present
privat
veterinarian
prompt
remov
pleural
effus
prior
come
uc
davi
residu
dyspnea
thorac
effus
respond
rapidli
treatment
longer
appar
day
jaundic
slowli
resolv
week
parallel
decreas
hyperbilirubinemia
sign
ocular
diseas
began
clear
within
h
longer
appar
outwardli
ophthalmoscop
examin
day
enlarg
mesenter
ileocecalcol
lymph
node
slowli
decreas
size
cours
treatment
cat
appear
outwardli
normal
near
normal
estim
owner
week
treatment
emphasi
treatment
week
monitor
sever
blood
test
paramet
key
valu
includ
pack
cell
volum
pcv
total
white
blood
cell
absolut
lymphocyt
count
total
serum
protein
serum
globulin
serum
albumin
albumin
globulin
g
ratio
eighteen
cat
complet
least
week
uninterrupt
primari
treatment
requir
treatment
howev
eight
cat
suffer
diseas
relaps
within
day
averag
day
figur
group
includ
three
cat
temporari
break
initi
treatment
five
cat
requir
extend
primari
treatment
figur
diseas
relaps
cat
clearli
neurolog
natur
high
fever
sever
posterior
ataxia
incoordin
diseas
relaps
remain
six
cat
consist
mainli
fever
anorexia
lack
activ
one
cat
obviou
abdomin
effus
upon
relaps
one
cat
euthan
week
suffer
relaps
neurolog
sign
fail
respond
second
round
treatment
decis
made
increas
dose
mgkg
eight
cat
either
treatment
extend
suffer
one
two
relaps
relaps
neurolog
eight
cat
respond
well
higher
dosag
regimen
total
cat
treat
week
longer
achiev
sustain
remiss
fip
although
one
subsequ
die
unrel
heart
problem
see
necropsi
find
longest
survivor
time
public
onlinefirst
februari
end
treatment
august
shortest
may
beyond
longest
time
relaps
occur
ie
day
stop
treatment
surviv
cat
care
monitor
return
diseas
sign
period
test
total
protein
globulin
albumin
g
ratio
first
year
less
intens
monitor
maintain
remaind
cat
live
owner
caution
avoid
unnecessari
stress
cat
first
month
although
four
cat
spay
one
cat
castrat
without
complic
simplest
longterm
measur
treatment
efficaci
bodi
weight
weight
gain
occur
follow
treatment
even
cat
year
age
older
diseas
onset
younger
cat
also
appear
grow
statur
increas
rate
independ
note
owner
posttreat
surg
growth
indic
fip
subclin
mani
cat
time
prior
diagnosi
affect
growth
cbc
chemistri
profil
also
prove
help
monitor
later
effect
treatment
observ
possibl
drug
toxic
cat
present
elev
white
blood
cell
count
drop
normal
level
within
first
week
treatment
figur
lymphopenia
note
time
entri
resolv
first
week
treatment
figur
mild
moder
sever
anemia
observ
entri
reflect
pack
cell
volum
pcv
figur
pcv
return
normal
level
week
treatment
therefor
absolut
total
white
cell
lymphocyt
count
valu
first
week
treatment
pcv
gave
accur
pictur
treatment
progress
first
week
cat
fip
frequent
present
higher
normal
total
serum
protein
concentr
high
serum
globulin
low
serum
albumin
level
low
g
ratio
figur
abnorm
serum
protein
valu
improv
progress
reach
normal
level
week
treatment
figur
level
total
protein
least
inform
indic
weak
valu
trend
line
figur
howev
dramat
transient
rise
total
protein
level
occur
week
treatment
figur
associ
increas
serum
globulin
figur
occur
time
abdomin
effus
rapidli
resolv
plasma
globulin
level
rose
first
week
treatment
peak
slowli
drop
maximum
refer
valu
gdl
lower
week
figur
although
globulin
level
time
appear
indic
statu
treatment
low
valu
made
less
reliabl
indic
treatment
progress
level
albumin
serum
cat
treat
least
week
usual
low
gdl
time
treatment
start
figur
albumin
level
increas
slowli
reach
normal
level
week
trend
line
rise
albumin
strong
valu
make
serum
albumin
level
well
pcv
good
indic
treatment
progress
expect
g
ratio
show
equal
strong
trendlin
time
reach
level
around
week
treatment
figur
sequenti
ascit
sampl
collect
eight
cat
first
day
antivir
treatment
test
level
viral
rna
qrtpcr
tabl
whole
effus
cell
fraction
reliabl
sourc
fipv
rna
viral
rna
level
decreas
often
undetect
level
day
cat
one
cat
fail
show
signific
drop
viral
rna
level
day
period
inject
site
reaction
two
type
whether
caus
drug
diluent
determin
immedi
pain
reaction
manifest
vocal
occasion
growl
postur
chang
last
initi
reaction
lessen
sever
time
owner
becam
adept
administ
inject
cat
becam
adjust
routin
sixteen
treat
cat
manifest
inject
site
reaction
tabl
reaction
common
first
week
progress
open
sore
cat
ulcer
heal
within
week
clip
surround
hair
gentli
clean
wound
cotton
ball
soak
onepart
household
hydrogen
peroxid
twopart
water
twice
day
three
cat
notic
scar
inject
site
treatment
total
period
week
remark
safe
longterm
abnorm
observ
cbc
valu
figur
test
liver
kidney
function
level
amylaselipas
remain
normal
treatment
supplementari
figur
except
cat
progress
rise
blood
urea
nitrogen
bun
mgdl
refer
interv
ri
sudden
rise
sdma
ri
week
third
round
treatment
higher
mgkg
dosag
regimen
although
sign
still
mild
natur
decis
made
stop
treatment
caution
abnorm
evid
test
month
later
cat
current
diseas
remiss
four
cat
euthan
die
within
day
enrol
necropsi
perform
cat
fifth
cat
cat
euthan
day
treatment
five
cat
present
sever
abdomin
effus
diseas
cat
evid
upon
necropsi
widespread
pyogranulomat
vascul
involv
abdomin
viscera
central
nervou
system
eye
cat
also
compromis
ileal
wall
area
dens
infiltr
secondari
bacteri
sepsi
cat
sever
pyogranulomat
vascul
restrict
abdomen
moderatetosever
peripher
edema
miner
adren
cortic
cat
suffer
sever
pyogranulomat
fibrinosuppur
periton
complic
acut
gastric
perfor
associ
plant
materi
intralesion
bacteria
indic
sepsi
cat
present
chronic
form
fip
character
sever
stunt
growth
massiv
low
proteinlow
cell
abdomin
effus
gallop
rhythm
indic
impair
cardiac
function
moder
sever
peripher
edema
echocardiogram
show
bilater
atrial
enlarg
indic
primari
cardiac
diseas
cat
appear
respond
discharg
cat
went
shock
day
later
euthan
without
necropsi
fipv
detect
qrtpcr
cat
time
necropsi
although
pretreat
ascit
sampl
test
posit
ascit
cat
test
posit
qrtpcr
throughout
treatment
tabl
tissu
still
posit
immunohistochemistri
time
necropsi
two
addit
cat
euthan
success
complet
one
round
treatment
cat
normal
one
round
treatment
relaps
sever
neurolog
sign
week
later
cat
fail
respond
retreat
euthan
lesion
typic
fip
found
within
brain
abdomen
neg
fipv
immunohistochemistri
nucleocapsid
protein
rna
qrtpcr
cat
success
treat
effus
abdomin
fip
develop
intens
hindleg
lower
back
pain
week
later
euthan
cat
found
pronounc
thicken
left
ventricular
wall
septum
caus
sever
constrict
chamber
figur
microscop
appear
left
cardiac
ventricular
wall
typic
congenit
felin
hypertroph
cardiomyopathi
hcm
gross
microscop
lesion
fip
found
abdomen
chest
eye
brain
spine
fipv
antigen
rna
detect
qrtpcr
second
target
antivir
drug
evalu
treatment
cat
fip
past
two
three
two
drug
inhibit
viral
replic
two
differ
manner
either
termin
viral
rna
transcript
block
viral
polyprotein
cleavag
process
wellestablish
target
sever
viral
diseas
key
question
treatment
nucleosid
analog
compar
viral
proteas
inhibitor
two
drug
gave
virtual
ident
result
tissu
cultur
experiment
cat
infect
howev
efficaci
natur
occur
fip
appear
greater
six
cat
treat
remain
remiss
date
pedersen
nc
unpublish
data
compar
cat
treat
diseas
relaps
respond
retreat
occur
cat
one
cat
treat
eight
relaps
associ
neurolog
compar
relaps
one
two
neurolog
relaps
cat
respond
retreat
higher
dosag
wherea
neurolog
relaps
even
increas
dosag
longer
treatment
caus
similar
inject
site
reaction
drug
appear
quit
safe
although
interf
develop
perman
teeth
given
younger
although
result
field
test
appear
favor
differ
may
influenc
two
drug
administ
efficaci
may
improv
cat
treat
without
interrupt
week
rather
treat
progress
longer
period
start
five
six
cat
cure
among
seven
cat
treat
continu
week
one
cat
treat
one
time
shorter
period
time
cure
shorter
treatment
time
essenti
determin
week
period
use
cat
present
studi
field
trial
also
involv
fewer
cat
constrain
limit
suppli
drug
made
difficult
test
dosag
regimen
therefor
studi
use
minimum
week
higher
dosag
larger
number
cat
make
final
comparison
would
also
import
time
futur
evalu
type
drug
combin
done
hivaid
hepat
c
earli
death
must
anticip
trial
type
consid
analyz
efficaci
five
earli
death
studi
includ
analysi
efficaci
remov
consider
trial
includ
trial
import
determin
viru
statu
time
death
viral
rna
detect
three
necropsi
cat
die
day
treatment
suggest
drug
effect
diseas
process
far
advanc
appear
case
fourth
necropsi
cat
surviv
day
viral
rna
level
decreas
entir
treatment
period
diseas
sign
unab
therefor
possibl
cat
die
failur
halt
viru
replic
resist
remdesivir
prodrug
associ
amino
acid
mutat
rna
polymeras
proofread
exonucleas
tissu
cultur
propag
whether
similar
type
resist
occur
cat
remain
determin
drug
resist
also
seen
one
cat
fortun
none
cat
current
trial
show
sign
drug
resist
time
howev
someth
need
consid
futur
cat
fail
respond
respond
poorli
primari
secondari
treatment
initi
dosag
use
present
studi
determin
prior
pharmacokinet
experiment
infect
studi
laboratori
studi
indic
mgkg
sc
day
would
equal
effect
field
test
therefor
mgkg
dose
chosen
field
trial
would
cut
drug
usag
although
decis
valid
cat
eight
cat
either
suffer
diseas
relaps
two
second
time
requir
longer
treatment
period
get
key
blood
valu
back
normal
therefor
decis
made
increas
dosag
mgkg
mgkg
sc
cat
relaps
requir
extend
treatment
success
mgkg
sc
least
cat
well
one
cat
neurolog
diseas
led
us
conclus
effect
dosag
basi
futur
treatment
import
follow
simpl
biolog
marker
progress
week
treatment
period
pcv
serum
total
protein
globulin
albumin
level
g
ratio
identifi
use
marker
base
paramet
appear
cat
complet
recov
week
treatment
find
valid
week
minimum
treatment
period
determin
earlier
field
anemia
chronic
diseas
anemia
inflamm
affect
peopl
acut
chronic
infect
normocyticnormochrom
associ
iron
plasma
albumin
level
also
good
measur
diseas
activ
low
albumin
low
pcv
known
coincid
situat
chronic
hyperglobulinemia
cat
fip
classifi
infectiousinflammatori
caus
increas
gamma
globulin
class
variabl
increas
strong
tendenc
cat
fip
high
serum
globulin
low
albumin
level
make
g
ratio
particularli
good
indic
diseas
expect
pedigre
cat
would
respond
well
treatment
genet
weak
abil
respond
immunolog
younger
cat
effus
fip
would
howev
pedigre
cat
present
trial
respond
equal
well
randombr
cat
breed
repres
cat
studi
mainli
mirror
breed
current
popular
older
cat
cat
pure
noneffus
fip
also
respond
well
treatment
young
cat
cat
effus
fip
proport
cat
ocular
neurolog
diseas
also
success
treat
clinic
manifest
fip
consid
untreat
safeti
profil
impress
system
sign
toxic
base
cbc
serum
chemistri
valu
observ
total
treatment
period
week
one
possibl
except
one
cat
mild
rise
bun
sdma
week
third
round
treatment
prompt
halt
precautionari
measur
base
previou
experi
concern
effect
develop
perman
dentit
three
cat
present
studi
month
age
younger
still
juvenil
dentit
none
show
subsequ
dental
abnorm
inject
site
reaction
observ
remark
low
number
easili
treat
determin
whether
drug
diluent
fault
ph
diluent
well
minimum
food
drug
administr
fda
threshold
drug
type
difficult
solubil
stabil
physiolog
ph
nonetheless
physiolog
diluent
evalu
one
cat
studi
confound
clinic
sign
although
cat
present
effus
abdomin
fip
also
longstand
sign
vagu
hindlimb
lame
lower
back
pain
period
bout
fall
reluct
jump
higher
place
unexplain
transient
chang
behavior
sign
prompt
cat
treat
long
time
abdomin
effus
disappear
decis
ultim
made
discontinu
treatment
see
characterist
fip
sign
would
recur
cat
ultim
euthan
found
congenitaltyp
hcm
residu
lesion
fip
viral
rna
tissu
upon
necropsi
dilat
cardiomyopathi
report
hivinfect
peopl
chronic
antiretrovir
conclud
howev
caus
heart
diseas
cat
heart
diseas
cat
hypertroph
rather
dil
form
seen
patient
hiv
hcm
common
condit
among
shelter
result
obtain
cat
treat
exceed
expect
indic
fip
regardless
signal
diseas
form
treatabl
diseas
use
nucleosid
analog
studi
design
treatment
paramet
determin
limit
field
trial
essenti
futur
effort
commerci
similar
drug
fip
